Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

microRNAs as Early Biomarkers of Alzheimer’s Disease: A Synaptic Perspective
Dolores Siedlecki‐Wullich, Alfredo J. Miñano‐Molina, José Rodrı́guez-Álvarez
Cells (2021) Vol. 10, Iss. 1, pp. 113-113
Open Access | Times Cited: 56

Showing 26-50 of 56 citing articles:

MicroRNAs modulation by curcumin, catalpol, and other natural products in Alzheimer’s disease: a review
Amir Modarresi Chahardehi, Reza Arefnezhad, Alireza Pourbafrani, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Posttranscriptional regulation of Nrf2 through miRNAs and their role in Alzheimer's disease
Ravinder K. Kaundal, Ashok Kumar Datusalia, Shyam Sundar Sharma
Pharmacological Research (2021) Vol. 175, pp. 106018-106018
Closed Access | Times Cited: 23
New RNA-Based Breakthroughs in Alzheimer’s Disease Diagnosis and Therapeutics
Micaela Riscado, Bruno Baptista, Fani Sousa
Pharmaceutics (2021) Vol. 13, Iss. 9, pp. 1397-1397
Open Access | Times Cited: 21
FMRP-Driven Neuropathology in Autistic Spectrum Disorder and Alzheimer's disease: A Losing Game
Louis Bleuzé, Viviana Triaca, Antonella Borreca
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 21
Alzheimer’s Disease Diagnostics Using miRNA Biomarkers and Machine Learning
A.J. Xu, Valentina L. Kouznetsova, Igor F. Tsigelny
Journal of Alzheimer s Disease (2022) Vol. 86, Iss. 2, pp. 841-859
Closed Access | Times Cited: 16
Sera miR-34a, miR-29b and miR-181c as potential novel diagnostic biomarker panel for Alzheimers in the Egyptian population
Nermeen Z. Abuelezz, Fayza Eid Nasr, Waleed M. Abdel Aal, et al.
Experimental Gerontology (2022) Vol. 169, pp. 111961-111961
Closed Access | Times Cited: 15
Neuroprotective effects of G9a inhibition through modulation of peroxisome-proliferator activator receptor gamma-dependent pathways by miR-128
Aina Bellver‐Sanchís, Pedro Antonio Ávila-López, Iva Tic, et al.
Neural Regeneration Research (2024) Vol. 19, Iss. 11, pp. 2532-2542
Open Access | Times Cited: 3
Potential Application of MicroRNAs and Some Other Molecular Biomarkers in Alzheimer’s Disease
Olga Paprzycka, Jan Wieczorek, Ilona Nowak, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 6, pp. 5066-5084
Open Access | Times Cited: 3
Ginkgo Biloba Extract Ameliorates Scopolamine-induced Memory Deficits via Rescuing Synaptic Damage
Gui-jiao Zhang, Dong Zheng, Huan Yu, et al.
Current Medical Science (2022) Vol. 42, Iss. 3, pp. 474-482
Open Access | Times Cited: 13
Downregulation of Neurofilament Light Chain Expression in Human Neuronal-Glial Cell Co-Cultures by a Microbiome-Derived Lipopolysaccharide-Induced miRNA-30b-5p
Aileen I. Pogue, Vivian Jaber, Nathan M. Sharfman, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 13
A Review of miRNAs as Biomarkers and Effect of Dietary Modulation in Obesity Associated Cognitive Decline and Neurodegenerative Disorders
Maddie Perdoncin, Alec Konrad, Joshua R. Wyner, et al.
Frontiers in Molecular Neuroscience (2021) Vol. 14
Open Access | Times Cited: 17
The Potential Role of miRNAs in Cognitive Frailty
Giulia Carini, Laura Musazzi, Francesco Bolzetta, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 17
MicroRNA-Based Diagnosis and Therapeutics for Vascular Cognitive Impairment and Dementia
Weijie Zhai, Meng Zhao, Guimei Zhang, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 12
Role of Post-Transcriptional Regulation in Learning and Memory in Mammals
Carlo Maria Di Liegro, Gabriella Schiera, Giuseppe Schirò, et al.
Genes (2024) Vol. 15, Iss. 3, pp. 337-337
Open Access | Times Cited: 2
Novel Panel of Long Noncoding RNAs as Diagnostic Biomarkers for Amnestic Mild Cognitive Impairment in Peripheral Blood
Tao Wang, Wei Zhang, Joshua M.A. Maclin, et al.
Journal of Alzheimer s Disease (2024) Vol. 99, Iss. 4, pp. 1385-1396
Closed Access | Times Cited: 2
Neuroepigenetic Mechanisms of Action of Ultrashort Peptides in Alzheimer’s Disease
Anastasiia Ilina, Khavinson VKh, N. S. Linkova, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4259-4259
Open Access | Times Cited: 11
Nucleic acid liquid biopsies in Alzheimer's disease: current state, challenges, and opportunities
Tabea M. Soelter, Jordan H. Whitlock, Avery S. Williams, et al.
Heliyon (2022) Vol. 8, Iss. 4, pp. e09239-e09239
Open Access | Times Cited: 11
Brain Targeting of Citicoline Sodium via Hyaluronic Acid-Decorated Novel Nano-Transbilosomes for Mitigation of Alzheimer’s Disease in a Rat Model: Formulation, Optimization, in vitro and in vivo Assessment
Kariman M. AbouElhassan, Hatem A. Sarhan, Amal K. Hussein, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 6347-6376
Open Access | Times Cited: 11
Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature
Sara Redenšek, David Vogrinc, Katja Goričar, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 6
The cumulative effect of the combined action of miR-101 and curcumin in a liposome on a model of Alzheimer’s disease in mononuclear cells
Victoria V. Sokolik, О. Г. Берченко
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 5
Insights into the Role of microRNAs as Clinical Tools for Diagnosis, Prognosis, and as Therapeutic Targets in Alzheimer’s Disease
Nidhi Puranik, Minseok Song
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9936-9936
Open Access | Times Cited: 1
Sporadic Alzheimer’s Disease- and Neurotoxicity-Related microRNAs Affecting Key Events of Tau-Driven Adverse Outcome Pathway Toward Memory Loss
Maria Tsamou, Donatella Carpi, Francesca Pistollato, et al.
Journal of Alzheimer s Disease (2022) Vol. 86, Iss. 3, pp. 1427-1457
Closed Access | Times Cited: 5
Diagnosis in Scrapie: Conventional Methods and New Biomarkers
Diego Sola, Marina Betancor, P Lorente, et al.
Pathogens (2023) Vol. 12, Iss. 12, pp. 1399-1399
Open Access | Times Cited: 1
MiR-502-3p/miR-501-3p as potential synaptic biomarker in Alzheimer’s Disease: Analysis based on cerebrospinal fluid and neuropathology
Davin Devara, Bhupender Sharma, Melissa M. Torres, et al.
Research Square (Research Square) (2024)
Open Access
Noncoding RNAs in Alzheimer’s Disease: Overview of Functional and Therapeutic Significance
Divya Adiga, Sangavi Eswaran, Sriharikrishnaa Srinath, et al.
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 19, pp. 1615-1634
Closed Access

Scroll to top